Sign In
CLOV.US
id: 686

Clover Health Investments (CLOV) $22M Investor Settlement

M.D. Tennessee
Court
3:21-cv-00096
Case number
06 Oct 2020
Class period Start
03 Feb 2021
Class period End
09 Oct 2023
Claim deadline
Clover Health Investments settles $22 million with Investors to end claims over concealing DOJ investigation $CLOV faced in the lead-up to its go-public merger with a SPAC.
Case Status
Accepting Late Claims
Alleged Offence
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Payout per Share
0.22
Filing date
05 February 2021
Plaintiffs
Firas Jabri, Jean-Nicolas Tremblay
Attorneys
Bramlett Law Offices (Nashville, TN), Pomerantz LLP (New York, NY), The Schall Law Firm (Los Angeles, CA)
Defendants
Vivek Garipalli, Andrew Toy, Joseph Wagner, Chamath Palihapitiya
Judge
Hon. Aleta A. Trauger
Administrator
JND Legal Administration
Settlement agreement date
2023-05-25
Court hearing date
02 October 2023
Exclusion deadline
11 September 2023
Objection deadline
11 September 2023
Hearing deadline
11 September 2023
Trades matching type
FIFO
+$22,000,000
Cash Settlement Amount

Clover Health Investments Corp

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-base...

    Ticker
    CLOV.US
    ISIN
    US18914F1030
    CIK
    1144514
    Sector
    Healthcare
    Industry
    Healthcare Plans
    Country
    USA
    Address
    3401 Mallory Lane, Franklin, TN, United States, 37067